Biomarkers Market Size, Share, Growth & Industry Analysis, By Type (Protein Biomarkers, Genetic Biomarkers, Metabolic Biomarkers, Imaging Biomarkers), By Application (Disease Diagnosis, Disease Prognosis, Drug Discovery and Development, Personalized Medicine), By Disease Indication (Cancer, Infectious Disease, Others), and Regional Analysis, 2024 - 2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL BIOMARKERS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL BIOMARKERS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF REGULATORY FRAMEWORKS

6 GLOBAL BIOMARKERS MARKET, BY TYPE
6.1 Overview
6.2 Protein Biomarkers
6.3 Genetic Biomarkers
6.4 Metabolic Biomarkers
6.5 Imaging Biomarkers

7 GLOBAL BIOMARKERS MARKET, BY APPLICATION
7.1 Overview
7.2 Disease Diagnosis
7.3 Disease Prognosis
7.4 Drug Discovery and Development
7.5 Personalized Medicine

8 GLOBAL BIOMARKERS MARKET, BY DISEASE INDICATION
8.1 Overview
8.2 Cancer
8.3 Infectious Disease
8.4 Immunological Disorder
8.5 Cardiovascular Disorder
8.6 Others

9 GLOBAL BIOMARKERS MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 France
11.2 UK
11.3 Spain
11.4 Germany
11.5 Italy
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 Australia
12.5 ASEAN
12.6 South Korea
12.7 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 Turkey
13.2 UAE
13.3 Saudi Arabia
13.4 South Africa
13.5 Rest of Middle East & Africa

14 SOUTH AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL BIOMARKERS MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Thermo Fisher Scientific Inc.
16.2 F. Hoffmann-La Roche Ltd
16.3 Agilent Technologies, Inc.
16.4 Bio-Rad Laboratories, Inc.
16.5 Siemens
16.6 QIAGEN
16.7 PerkinElmer Inc.
16.8 BIOMÉRIEUX
16.9 Fujirebio
16.10 GE HealthCare
16.11 Almac Group
16.12 Caris Life Sciences.
16.13 Denovo Biopharma LLC 
16.14 Eurofins Scientific
16.15 MESO SCALE DIAGNOSTICS, LLC., and 
16.16 Others

LIST OF TABLES

TABLE 1 Global Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 2 Global Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 3 Global Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 4 Global Biomarkers Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 7 North America Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 8 North America Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 9 US Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 10 US Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 11 US Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 12 Canada Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 13 Canada Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 14 Canada Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 18 Europe Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 20 Europe Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 21 Europe Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 22 Germany Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 23 Germany Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 24 Germany Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 25 France Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 26 France Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 27 France Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 28 U.K. Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 29 U.K. Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 30 U.K. Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 31 Spain Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 32 Spain Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 33 Spain Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 34 Italy Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 35 Italy Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 36 Italy Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 37 Russia Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 38 Russia Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 39 Russia Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 47 China Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 48 China Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 49 China Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 50 Japan Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 51 Japan Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 52 Japan Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 53 India Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 54 India Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 55 India Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 56 Australia Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 57 Australia Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 58 Australia Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 59 ASEAN Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 60 ASEAN Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 61 ASEAN Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 62 South Korea Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 63 South Korea Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 64 South Korea Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 65 Rest of Asia-Pacific Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 66 Rest of Asia-Pacific Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 67 Rest of Asia-Pacific Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 68 Middle East and Africa Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 69 Middle East and Africa Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 70 Middle East and Africa Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 71 Middle East and Africa Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 72 Turkey Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 73 Turkey Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 74 Turkey Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 75 UAE Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 76 UAE Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 77 UAE Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 78 Saudi Arabia Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 79 Saudi Arabia Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 80 Saudi Arabia Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 81 South Africa Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 82 South Africa Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 83 South Africa Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 84 Rest of Middle East & Africa Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 85 Rest of Middle East & Africa Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 86 Rest of Middle East & Africa Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 87 South America Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 88 South America Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 89 South America Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 90 South America Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 91 Brazil Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 92 Brazil Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 93 Brazil Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 94 Argentina Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 95 Argentina Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 96 Argentina Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 97 Rest of South America Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 98 Rest of South America Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 99 Rest of South America Biomarkers Market Revenue, By Disease Indication, 2021 – 2031 (USD Billion)
TABLE 100 Company Market Ranking
TABLE 101 Regional Footprint
TABLE 102 Product Benchmarking
TABLE 103 Recent Developments
TABLE 104 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Biomarkers Market 2021-2031 (USD Billion)
FIG. 4 Global Biomarkers Market Geographical Analysis (CAGR %)
FIG. 5 Global BIOMARKERS Absolute Market Opportunity (USD Billion)
FIG. 6 Global Biomarkers Market Attractiveness (USD Billion)
FIG. 7 Global Biomarkers Market, By Type, 2021-2031 (USD Billion)
FIG. 8 Global Biomarkers Market, By Application, 2021-2031 (USD Billion)
FIG. 9 Global Biomarkers Market, By Disease Indication, 2021-2031 (USD Billion)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 MARKET DYNAMICS OVERVIEW
FIG. 15 Porter's Five Forces Analysis
FIG. 16 VALUE CHAIN ANALYSIS
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Biomarkers Market Revenue Share, By Type, 2020 and 2030 (%)
FIG. 19 Global Biomarkers Market Revenue Share, By Application, 2020 and 2030 (%)
FIG. 20 Global Biomarkers Market Revenue Share, By Disease Indication, 2020 and 2030 (%)
FIG. 21 Global Biomarkers Market Revenue Share, By Geographic Regions, 2020 and 2030 (%)
FIG. 22 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 23 North America Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 25 Europe Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 27 Asia-Pacific Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 29 Middle East & Africa Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2020 - 2030 (USD Billion)
FIG. 31 South America Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis